CDX2 and appendix adenocarcinoma: CDX2 is typically expressed in a strong diffuse pattern in colorectal and appendiceal adenocarcinomas, with sensitivity of 100% [15], in contrast to their analogs in the upper GI and ovaries, where it is expressed focally.